Sera Prognostics (SERA) Depreciation & Amortization (CF) (2020 - 2026)
Sera Prognostics' (SERA) quarterly Depreciation & Amortization (CF) came in at $193000.0 in Q1 2026, down 10.65% YoY from $216000.0 in Q1 2025, and down 20.9% on a QoQ basis from $244000.0 in Q4 2025.
Sera Prognostics (SERA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $193000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 10.65% year-over-year to $193000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $917000.0 (up 10.88% YoY) and the FY2025 annual result came in at $940000.0, up 12.85% from the prior year.
- Depreciation & Amortization (CF) eased to $193000.0 in Q1 2026, from $244000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $244000.0 in Q4 2025 to a low of $193000.0 in Q1 2026.
- A 5-year average of $212117.6 and a median of $200000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 100.0% — and 2026, when it retreated 10.65%.
- Tracing SERA's Depreciation & Amortization (CF) over 5 years: stood at $200000.0 in 2022, then climbed by 6.0% to $212000.0 in 2023, then declined by 0.47% to $211000.0 in 2024, then grew by 15.64% to $244000.0 in 2025, then declined by 20.9% to $193000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $193000.0 (Q1 2026), $244000.0 (Q4 2025), and $243000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Sera Prognostics | 103.23 Mn | 103.23 Mn | -20,000.00 | 191,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 191,000.00 |
| Jun 30, 2026 | 191,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Mar 31, 2024 | 213,000.00 |